Investigating the Role of Laboratory and Antigen in Repeatability of Results in Newcastle Virus Hemagglutination Inhibition

Document Type : Short Communication

Authors

1 Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran

2 Department of Poultry Viral Diseases, Razi Vaccine and Serum Research Institute, Karaj, Iran

3 Department of Clinical Sciences, Faculty of Veterinary Medicine, Karaj Branch, Islamic Azad University, Karaj, Iran

Abstract

Hemagglutination Inhibition (HI) test is a universal method in veterinary laboratories that has low sensitivity and high specificity in determining the level of antibody. This study aimed to evaluate the repeatability of HI test and to determine the suitable antigen for HI test. Two experiments were conducted in this study. In the first, 60 serum samples were divided into four groups, including negative, low, medium, and high titer serums for Newcastle virus. Also, to evaluate the repeatability of the HI test results, eight pairs of repeating serums were placed from all four serum groups. The sera were sent to 11 different veterinary laboratories, and asked to determine the Newcastle HI titers by standard protocols. In second experiment, 41 sera were used to determine the appropriate antigen using five antigens (Clone Lasota, Lasota, B1, commercial and laboratory antigen) for the HI test. the first experiment showed that most laboratories could identify high titers, but there is a significant difference in determining zero, low, and medium titers. Also, based on results obtained from each of laboratories, it was found that the reproducibility of HI results within a laboratory is low.  In the second experiment, the best antigen was determined in terms of the same answers for use in the HI antigen test of Lasota Clone vaccine. This study is the first study on the quality control of the HI in Iran. The results showed that the quality of test is not satisfactory, and the IVO and research centers should standardize this test.

Keywords

References

1- Ahmadi, E., S. A. Pourbakhsh, M. Ahmadi and A. Talebi. 2014. Pathotypic characterization of the Newcastle disease virus isolated from commercial poultry in northwest Iran. Turkish Journal of Veterinary and Animal Sciences 38: 383-387.
2- Beard, C., S. Hopkins  and J. Hammond. 1975. Preparation of Newcastle disease virus hemagglutination-inhibition test antigen. Avian diseases: 692-699.
3- Beard, C. and  W. Wilkes. 1985. A comparison of Newcastle disease hemagglutination-inhibition test results from diagnostic laboratories in the southeastern United States. Avian diseases: 1048-1056.
4- Brugh Jr, M., C. Beard and W. Wilkes. 1978. The influence of test conditions on Newcastle disease hemagglutination-inhibition titers. Avian diseases: 320-328.
5- Cox, R. M. and R. K. Plemper. 2017. Structure and organization of paramyxovirus particles. Current Opinion in Virology 24: 105-114.
6- Dimitrov, K. M., C. Abolnik, C. L.  Afonso, E. Albina, J.  Bahl,  M. Berg and et al. 2019. Updated unified phylogenetic classification system and revised nomenclature for Newcastle disease virus. Infection, Genetics and Evolution 74: 103917.
7- Dimitrov, K. M., A. M. Ramey, X. Qiu, J.  Bahl  and C. L. Afonso. 2016. Temporal, geographic, and host distribution of avian paramyxovirus 1 (Newcastle disease virus). Infection, genetics and evolution 39: 22-34.
8- Kaufmann, L., Syedbasha, M., Vogt, D., Hollenstein, Y., Hartmann, J., Linnik, J. E. and Egli, A. 2017. An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers. Journal  of  Visualized  Experiments 2017: 55833.
9- Mehrabanpour, M., M. R. Bushehri  and D. Mehrabanpour. 2017. Molecular and serological diagnosis of Newcastle and Ornithobacterium rhinotracheale broiler in chicken in Fars Province, Iran. International Journal of Biological, Biomolecular, Agricultural, Food and Biotechnological Engineering 11: 224-227.
10- Nagai, Y., H. D. Klenk and R. Rott. (1976). Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology 72: 494-508.
11- Rajmani, R. S., S. K. Gupta, P. K. Singh, P. K. Gandham, A. P.  Sahoo, U. Chaturvedi  and A. K. Tiwari. 2016. HN protein of Newcastle disease virus sensitizes HeLa cells to TNF-α-induced apoptosis by downregulating NF-κB expression. Archive Virology 161: 2395-2405.
12- Reber, A. and  J.  Katz. 2013. Immunological assessment of influenza vaccines and immune correlates of protection. expert review vaccines 12: 519-536.
13- Saadat, Y., S. A. Ghafouri, F.  Tehrani and A. G. Langeroudi. 2014. An active serological survey of antibodies to newcastle disease and avian influenza (H9N2) viruses in the unvaccinated backyard poultry in Bushehr province,Iran, 2012–2013. Asian Pacific Journal of Tropical Biomedicine 4: S213-S216.
14- Sabouri, F., M. Vasfi Marandi and M. Bashashati. 2018. Characterization of a novel VIIl sub-genotype of Newcastle disease virus circulating in Iran. Avian Pathol 47: 90-99.
15- Stephenson, I., A. Heath, D.  Major, R. W.  Newman, K.  Hoschler, W.  Junzi, J. M. Katz, J. P.  Weir, M. C.  Zambon  and J. M. Wood. 2009. Reproducibility of serologic assays for influenza virus A (H5N1). Emerging infectious diseases 15: 1250.
16- Zacour, M., B. J. Ward, A.  Brewer, P.  Tang, G.  Boivin, Y.  Li, M.  Warhuus, S. A.  McNeil, J. J. LeBlanc  and T. F. Hatchette. 2016. Standardization of hemagglutination inhibition assay for influenza serology allows for high reproducibility between laboratories. Clinical Vaccine Immunology 23: 236-242.
 

Files

History

  • Receive Date: 08 October 2020
  • Revise Date: 17 December 2020
  • Accept Date: 28 December 2020

Share

How to cite

Statistics